BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21320601)

  • 1. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
    Shu Y; Cinier M; Shu D; Guo P
    Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
    Guo P
    J Nanosci Nanotechnol; 2005 Dec; 5(12):1964-82. PubMed ID: 16430131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
    Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
    Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
    Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
    Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
    Guo P; Shu Y; Binzel D; Cinier M
    Methods Mol Biol; 2012; 928():197-219. PubMed ID: 22956144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of Polyvalent Therapeutic RNA Nanoparticles for Specific Delivery of siRNA, Ribozyme and Drugs to Targeted Cells for Cancer Therapy.
    Shu Y; Shu D; Diao Z; Shen G; Guo P
    IEEE NIH Life Sci Syst Appl Workshop; 2009 May; 2009():9-12. PubMed ID: 21243099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in Phi29 pRNA biology and its application in drug delivery.
    Ye X; Hemida M; Zhang HM; Hanson P; Ye Q; Yang D
    Wiley Interdiscip Rev RNA; 2012; 3(4):469-81. PubMed ID: 22362726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
    Guo S; Tschammer N; Mohammed S; Guo P
    Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
    Shu Y; Shu D; Haque F; Guo P
    Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor.
    Guo S; Piao X; Li H; Guo P
    Methods; 2018 Jul; 143():121-133. PubMed ID: 29530505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene.
    Qiu C; Peng WK; Shi F; Zhang T
    Genet Mol Res; 2012 Sep; 11(3):3236-45. PubMed ID: 23079817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the inter-RNA interaction of bacterial virus phi29 packaging RNA by site-specific photoaffinity cross-linking.
    Garver K; Guo P
    J Biol Chem; 2000 Jan; 275(4):2817-24. PubMed ID: 10644747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.
    Reif R; Haque F; Guo P
    Nucleic Acid Ther; 2012 Dec; 22(6):428-37. PubMed ID: 23113765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The structure, function and recent reseach of pRNA].
    Zhou H; Lu XY; Tian Y; Huang CJ
    Yi Chuan; 2006 Sep; 28(9):1180-4. PubMed ID: 16963432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy.
    Lee TJ; Schwartz C; Guo P
    Ann Biomed Eng; 2009 Oct; 37(10):2064-81. PubMed ID: 19495981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modular assembly of chimeric phi29 packaging RNAs that support DNA packaging.
    Fang Y; Shu D; Xiao F; Guo P; Qin PZ
    Biochem Biophys Res Commun; 2008 Aug; 372(4):589-94. PubMed ID: 18514064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.
    Shu D; Khisamutdinov EF; Zhang L; Guo P
    Nucleic Acids Res; 2014 Jan; 42(2):e10. PubMed ID: 24084081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The procapsid binding domain of phi29 packaging RNA has a modular architecture and requires 2'-hydroxyl groups in packaging RNA interaction.
    Fang Y; Cai Q; Qin PZ
    Biochemistry; 2005 Jul; 44(26):9348-58. PubMed ID: 15982001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of phi29 DNA-packaging RNA monomers, dimers, and trimers with variable sizes and shapes as potential parts for nanodevices.
    Shu D; Huang LP; Hoeprich S; Guo P
    J Nanosci Nanotechnol; 2003 Aug; 3(4):295-302. PubMed ID: 14598442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNA.
    Zhang H; Endrizzi JA; Shu Y; Haque F; Sauter C; Shlyakhtenko LS; Lyubchenko Y; Guo P; Chi YI
    RNA; 2013 Sep; 19(9):1226-37. PubMed ID: 23884902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.